Betsy Winnekens
Surgery · Neenah, WINPI 1740469881
Payments from drug & device makers
Across 61 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$375
- AbbVie$367
- Johnson & Johnson$146
- Novo Nordisk$77
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
- Vertex$44
- plus $277 from 11 others
What the payments were for
- Food & beverage$1,346100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $375 |
| AbbVie | 16 | $367 |
| Johnson & Johnson(2 entities) | 7 | $146 |
| Novo Nordisk | 4 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $59 |
| Vertex | 2 | $44 |
| Teleflex LLC | 2 | $40 |
| TELA Bio, Inc. | 1 | $34 |
| Integra Lifesciences Corporation | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| CSL Behring | 1 | $24 |
| Octapharma USA, Inc. | 1 | $24 |
| Amgen | 1 | $22 |
| Dilon Technologies, Inc. | 1 | $21 |
| Merck | 1 | $19 |
| KCI USA, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
How this compares
$1,346 in reported general payments places this provider in the 50th percentile of 499 surgery providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 41 | $1,664 |
| Omeprazole | 81 | $913 |
| Enoxaparin Sodium | 12 | $706 |
| Ondansetron OdtOndansetron | 49 | $289 |
| Pantoprazole Sodium | 17 | $147 |
| Oxycodone Hcl | 62 | $142 |
| Gabapentin | 12 | $96 |
| Cyclobenzaprine Hcl | 20 | $44 |
| Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12) | 12 | $41 |
| Celecoxib | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other surgery in Neenah
- Raymond GeorgenNeenah$325K
- Peter UllrichAppleton$18M
- Jeffrey AndersonMilwaukee$1.4M
- Matthew GoldblattMilwaukee$898K
- Geoffrey RoelantEau Claire$719K
- Juan DanobeitiaMadison$310K
- Cynthia GeocarisGreen Bay$263K
- Peter JanuChilton$157K
- Rana HigginsMilwaukee$148K
- Mustafa BadruddujaKenosha$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.